Skip to main content

Johns Hopkins University

13F filer · CIK 0001764756
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$1.5BU.S. long equity reported on 13F
Positions95 new · 0 closed
Net flow last quarter+$36.8MBuys minus sells
Top 10 positions weight25.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 20269 positions
QQQInvesco QQQ Trust, Series 1$190M12.73%Not reportedNot reportedQ1 2025
EMXCEmax Holdings Corp$146M9.74%Not reportedNot reportedQ4 2024
GOOGLAlphabet Inc.$12M0.80%0.00%NewQ2 2026
AMZNAmazon Com Inc$11.2M0.75%0.00%NewQ2 2026
MSFTMicrosoft Corp$10.1M0.67%0.00%NewQ2 2026
NBISNebius Group N.V.$2.3M0.15%0.00%NewQ2 2026
TUSKMammoth Energy Services, Inc.$1.26M0.08%0.80%NewQ2 2026
MSTRStrategy Inc$730K0.05%Not reportedNot reportedQ2 2025
BRNSBarinthus Biotherapeutics plc.$80.7K0.01%0.30%Not reportedQ4 2021
Q1 2026Reported May 14, 20264 positions
QQQInvesco QQQ Trust, Series 1$149M10.81%Not reportedNot reportedQ1 2025
EMXCEmax Holdings Corp$112M8.12%Not reportedNot reportedQ4 2024
MSTRStrategy Inc$1.05M0.08%Not reportedNot reportedQ2 2025
BRNSBarinthus Biotherapeutics plc.$69.6K0.01%0.30%Not reportedQ4 2021
Q4 2025Reported Feb 17, 20265 positions
QQQInvesco QQQ Trust, Series 1$159M11.57%Not reportedNot reportedQ1 2025
EMXCEmax Holdings Corp$103M7.54%Not reportedNot reportedQ4 2024
ABNBAirbnb, Inc.$2.01M0.15%Not reportedNot reportedQ1 2023
MSTRStrategy Inc$1.28M0.09%Not reportedNot reportedQ2 2025
BRNSBarinthus Biotherapeutics plc.$85.6K0.01%0.30%Not reportedQ4 2021
Q3 2025Reported Nov 17, 20256 positions
QQQInvesco QQQ Trust, Series 1$155M8.65%Not reportedNot reportedQ1 2025
EMXCEmax Holdings Corp$96.1M5.36%Not reportedNot reportedQ4 2024
USRTEnigma-Bulwark, Ltd.$51M2.84%Not reportedNot reportedQ1 2025
PDDPDD Holdings Inc.$1.86M0.10%0.00%Not reportedQ3 2021
IOTSamsara Inc.$217K0.01%Not reported-89.9%Q3 2024
BRNSBarinthus Biotherapeutics plc.$153K0.01%0.30%Not reportedQ4 2021
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.